The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Anas Younes

Anas Younes

Professor Anas Younes is a Professor of Medicine at the Weill-Cornell Medical College, and the Special Advisor to the Chairman of Medicine for Research and the Steven A. Greenberg Chair in Lymphoma Research at the Memorial Sloan Kettering Cancer Center New York, US.

Educated at the Faculty of Medicine, Damascus University, Damascus, SY, Prof. Younes then went on to complete his residencies at the College of Medicine at the University of Toledo, Toledo, US, and at the SUNY Downstate Medical Center, Brooklyn, US. He then made the short move over to Memorial Sloan Kettering Cancer Center, New York, US, to complete his hematology-oncology fellowship.

In 1992, following his fellowship, Prof. Younes worked at The University of Texas MD Anderson Cancer Center, Houston, US, where he acted as a clinical researcher and treating physician for the next two decades. In 2013, Prof. Younes made the move back east to become the Chief of Lymphoma Service at the Memorial Sloan Kettering Cancer Center.

With particular interest in both non-Hodgkin and Hodgkin lymphomas, Prof. Younes works towards the development of novel targeted therapies for lymphoma, as well as the identification of biomarkers for treatment. He has been the Principal Investigator in over 60 clinical trials, including some of the pivotal trials around nivolumab and brentuximab vedotin in relapsed/refractory Hodgkin lymphoma, which resulted in FDA approvals.

Positions of responsibility/awards:

  • Member of the Scientific Advisory Board of the Lymphoma Research Foundation
  • Past Member of the National Cancer Institute Lymphoma Steering Committee
  • Leader of the National Cancer Institute-funded SPORE (Specialized Programs of Research Excellence) in lymphoma, both at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center
  • Principal Investigator of a SCOR grant supported by the Leukemia & Lymphoma Society